Organ failure in sepsis
- 11 September 2007
- journal article
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 9 (5) , 374-381
- https://doi.org/10.1007/s11908-007-0058-4
Abstract
The development of organ failure determines the course and prognosis of the septic patient. Although several successful clinical trials in recent years have raised the enthusiasm of intensivists, severe sepsis and septic shock still have an increasing incidence with more or less unchanged mortality. Recent sepsis research, including progress made in definitions, epidemiology, pathophysiology, diagnosis, standard and adjunctive therapy, and experimental approaches, is encouraging. This includes genomic information for stratifying subgroups of patients, a broader field of laboratory diagnostics due to clinical studies, and basic research on the cellular mechanisms of inflammation and organ dysfunction. Furthermore, new findings in pathogenesis and therapeutic approaches to organ failure merit attention. In this review, state-of-the-art publications are presented to elucidate the possible impact of sepsisinduced organ failure on clinical routine.Keywords
This publication has 44 references indexed in Scilit:
- Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis studyIntensive Care Medicine, 2007
- Microarray-based Analysis of Ventilator-induced Lung InjuryProceedings of the American Thoracic Society, 2007
- Influence of drotrecogin alpha (activated) infusion on the variation of Bax/Bcl-2 and Bax/Bcl-xl ratios in circulating mononuclear cells: A cohort study in septic shock patientsCritical Care Medicine, 2007
- Antioxidant vitamin therapy alters sepsis-related apoptotic myocardial activity and inflammatory responsesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in rats*Critical Care Medicine, 2006
- Do coagulation abnormalities contribute to sepsis associated organ failure?*Critical Care Medicine, 2006
- Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis*Critical Care Medicine, 2006
- Treatment of adult patients with sepsis‐induced coagulopathy and purpura fulminans using a plasma‐derived protein C concentrate (Ceprotin®)Vox Sanguinis, 2006
- LPS-Induced Acute Lung Injury is Attenuated by Phosphodiesterase Inhibition: Effects on Proinflammatory Mediators, Metalloproteinases, NF-??B, and ICAM-1 ExpressionPublished by Wolters Kluwer Health ,2006
- An essential role for complement C5a in the pathogenesis of septic cardiac dysfunctionThe Journal of Experimental Medicine, 2005